Abstract
Oxidative modification of low-density lipoprotein (LDL) in the arterial wall plays a key role in the pathogenesis of atherosclerosis. Under oxidative stress LDL is exposed to oxidative modifications by arterial wall cells including macrophages. Oxidative stress also induces cellular-lipid peroxidation, resulting in the formation of ‘oxidized macrophages’, which demonstrate increased capacity to oxidize LDL and increased uptake of oxidized LDL. Macrophage-mediated oxidation of LDL depends on the balance between pro-oxidants and antioxidants in the lipoprotein and in the cells. LDL is protected from oxidation by antioxidants, as well as by a second line of defense—paraoxonase 1 (PON1),which is a high-density lipoprotein-associated esterase that can hydrolyze and reduce lipid peroxides in lipoproteins and in arterial cells. Cellular paraoxonases (PON2 and PON3) may also play an important protective role against oxidative stress at the cellular level. Many epidemiological studies have indicated a protective role for a diet rich in fruits and vegetables against the development and progression of cardiovascular disease. A large number of studies provide data suggesting that consumption of dietary antioxidants is associated with reduced risk for cardiovascular diseases. Basic research provides plausible mechanisms by which dietary antioxidants might reduce the development of atherosclerosis. These mechanisms include inhibition of LDL oxidation, inhibition of cellular lipid peroxidation and consequently attenuation of cell-mediated oxidation of LDL. An additional possible mechanism is preservation/increment of paraoxonases activity by dietary antioxidants. This review chapter presents recent data on the anti-atherosclerotic effects and mechanism of action of three major groups of dietary antioxidants—vitamin E, carotenoids and polyphenolic flavonoids.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
References
Abbott CA, Mackness MI, Kumar S, Boulton AJ, Durrington PN (1995) Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler Thromb Vasc Biol 15:1812–1818
Ahmed Z, Ravandi A, Maguire GF, Emili A, Draganov D, La Du BN, Kuksis A, Connelly PW (2001) Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (pon-1) during high density lipoprotein oxidation with a peroxynitrite donor. J Biol Chem 276:24473–24481
Albertini R, Moratti R, De Luca G (2002) Oxidation of low-density lipoprotein in atherosclerosis from basic biochemistry to clinical studies. Curr Mol Med 6:579–592
Aviram M (1991) The contribution of the macrophage receptor for oxidized LDL to its cellular uptake. Biochem Biophys Res Commun 179:359–365
Aviram M (1993)Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis. 98:1–9
Aviram M (1995) Oxidative modification of low density lipoprotein and atherosclerosis. Isr J Med Sci 31:241–249
Aviram M (1996) Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis and the antiatherogenicity of antioxidants. Eur J Clin Chem Clin Biochem 34:599–608
Aviram M (1999a) Antioxidants in restenosis and atherosclerosis. Curr Interven Cardiol Rep 1:66–78
Aviram M (1999b) Does paraoxonase play a role in susceptibility to cardiovascular disease? Mol Med 5:381–386
Aviram M (2000) Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic Res 33:S85–S97
Aviram M. (2003a) Lipid peroxidation and atherosclerosis: the importance of selected patient groups analysis. Isr Med Assoc J 5:734–735
Aviram M (2003b) Dietary antioxidants stimulate the expression of paraoxonases which provides protection against atherosclerosis development. Curr Top Nutraceutical Res 1:183–191
Aviram M (2003c) Introduction to the serial review on paraoxonases, oxidative stress, and cardiovascular diseases. Free Radic Biol Med 37:1301–1303
Aviram M (2004) Introduction to the serial review on paraoxonases, oxidative stress, and cardiovascular diseases. Free Radic Biol Med 37:1301–1303
Aviram M, Eias K (1993) Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation. Ann Nutr Metab 37:75–84
Aviram M, Fuhrman B (1998a) LDL Oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants. Mol Cell Biochem 188:149–159
Aviram M, Fuhrman B (1998b) Polyphenolic flavonoids inhibit macrophage-mediated oxidation of LDL and attenuate atherogenesis. Atherosclerosis 137(Suppl): S45–S50
Aviram M, Fuhrman B (2003) Effects of flavonoids on the oxidation of LDL and atherosclerosis. In: Rich-Evans C, Packer L (eds) Flavonoids in health and disease, Vol II. Marcel Dekker, New York, pp 165–203
Aviram M, Rosenblat M (1994). Macrophage mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor. J Lipid Res 35:385–398
Aviram M, Rosenblat M (2003) Oxidative stress in cardiovascular diseases: role of oxidized lipoproteins in macrophage foam cell formation and atherosclerosis. In: Fuchs J, Podda M, Packer L (eds) Redox genome interactions in health and disease. Marcel Dekker, New York, pp 557–590
Aviram M, Rosenblat M (2004) Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic Biol Med 37:1304–1316
Aviram M, Rosenblat M, Etzioni A, Levy R (1996) Activation of NADPH oxidase is required for macrophage-mediated oxidation of low density lipoprotein. Metabolism 45:1069–1079
Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. (1998) Paraoxonase inhibits high density lipoprotein (HDL) oxidation and preserves its functions: A possible peroxidative role for paraoxonase. J Clin Invest 101:1581–1590
Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B (1999) Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 26:892–904
Aviram M, Dorenfeld L, Rosenblat M, Volkova N, Kaplan M, Hayek T, Presser D, Fuhrman B (2000a) Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in the atherosclerotic apolipoprotein E deficient mice. Am J Clin Nutr 71:1062–1076
Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, Billecke S, Draganov D, Rosenblat M (2000b) Human serum paraoxnases (PON 1), Q and R selectively decrease lipid peroxides in coronary and carotid atherosclerotic lesions: PON 1 esterase and peroxidase-like activities. Circulation 101:2510–2517
Aviram M, Rosenblat M, Gaitini D, Nitecki S, Hoffman A, Dornfeld L, Volkova N, Presser D, Attias J, Leiker H, Hayek T (2004a) Pomegranate juice consumption for 3 years by patients with carotid artery stenosis (CAS) reduces common carotid intima-media thickness (IMT), blood pressure and LDL oxidation. Clin Nutr 23:423–433
Aviram M, Vaya J, Fuhrman B (2004b) Licorice root flavonoid antioxidants reduce LDL oxidation and attenuate cardiovascular diseases. In: Packer L, Choon Nam O, Halliwell B (eds) Herbal and traditional medicine: Molecular aspects of health. CHIPS Texas, chap 27, pp595–614
Baoutina A, Dean RT, Jessup W (1998) Alpha-tocopherol supplementation of macrophages does not influence their ability to oxidize LDL. J Lipid Res. 39:114–130
Belinky PA., Aviram M, Mahmood S, Vaya J (1998a) Structural aspects of the inhibitory effect of glabridin on LDL oxidation. Free Radic Biol Med 24:1419–1429
Belinky PA, Aviram M, Fuhrman B, Rosenblat M, Vaya J (1998b) The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during is oxidation. Atherosclerosis 137:49–61
Beltowski J, Wojcicka G, Mydlarcyk M, Jamroz A (2002) Cerivastatin modulates plasma paraoxonase/arylesterase activity and oxidant-antioxidant balance in the rat. Pol J Pharmacol 54:143–150
Berliner JA, Heinecke JW (1996) The role of oxidized lipoproteins in atherosclerosis. Free Radic Biol Med 20:707–727
Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS (2000) Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 7:356(9237):1213–1218
Boaz M, Smetana S, Matas Z, Bor A, Pinchuk I, Fainaru M, Green MS, Lichtenberg D (2003) Lipid oxidation kinetics in hemodialysis patients with and without history of myocardial infarction. Isr Med Assoc J 10:692–696
Bobak M, Hense HW, Kark J, Kuch B, Vojtisek P, Sinnreich R, Gostomzyk J, Bui M von Eckardstein A, Junker R, Fobker M, Schulte H, Assmann G, Marmot M (1999) An ecological study of determinants of coronary heart disease rates: a comparison of Czech, Bavarian and Israeli men. Int J Epidemiol 28: 437–444
Boemi M, Leviev I, Sirolla C, Pieri C, Marra M, James RW (2001) Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation. Atherosclerosis 155:229–235
Burton GW, Joyce A, Ingold KU (1983) Is vitamin E the only lipid-soluble, chain breaking antioxidant in human blood plasma and erythrocyte membranes? Arch Biochem Biophys 221:281–290
Caccetta RA, Croft KD, Beilin LJ, Puddey IB (2000) Ingestion of red wine significantly increases plasma phenolic acid concentrations but does not acutely affect ex vivo lipoprotein oxidizability. Am J Clin Nutr 71:67–74
Cachia O, Benna JE, Pedruzzi E, Descomps B, Gougerot-Pocidalo MA, Leger CL (1998) Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47 (phox) membrane translocation and phosphorylation. J Biol Chem 273:32801–32805
Chan AC (1998) Vitamin E and atherosclerosis. J Nutr 128:1593–1596
Chopra M, Thurnham DI (1999) Antioxidants and lipoprotein metabolism. Proc Nutr Soc 58:663–671
Crawford RS, Kirk EA, Rosenfeld ME, LeBoeuf RC, Chait A (1998) Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 18:1506–1513
Cyrus T, Yao Y, Rokach J, Tang LX, Pratico D (2003) Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions. Circulation 107:521–523
De Rijke YB, Demacker PN, Assen NA, Sloots LM, Katan MB, Stalenhoef AF (1996) Red wine consumption does not affect oxidizability of low-density lipoprotein volunteers. Am J Clin Nutr 63:329–334
De Whalley CV, Rankin SM, Hoult RS, Jessup W, Leake DS (1990) Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 39:1743–1750
Dieber RM, Puhl H, Waeg G, Striegl G, Esterbauer H (1991) Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human LDLs and resistance to oxidation. J Lipid Res 32:1325–1332
Dugas TR, Morel DW, Harrison EH (1998) Impact of LDL carotenoid and alpha-tocopherol content on LDL oxidation by endothelial cells in culture. J Lipid Res 39:999–1007
Dugas TR, Morel DW, Harrison EH (1999) Dietary supplementation with beta-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low-density lipoprotein. Free Radic Biol Med 26:1238–1244
Durrington PN, Mackness B, Mackness MI (2001) Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 21:473–480
Draganov D, Stetson PL, Watson C, Billecke S, La Du BN (2000) Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J Biol Chem 275:33435–33442
Dwyer JH, Navab M, Dwyer KM, Hassan K, Sun P, Shircore A, Hama-Levy S, Hough G, Wang X, Drake T, Merz CN, Fogelman AM (2001) Oxygenated carotenoid lutein and progression of early atherosclerosis: the Los Angeles atherosclerosis study. Circulation 103:2922–2927
Emmert DH, Kirchner JT (1999) The role of vitamin E in the prevention of heart disease. Arch Fam Med 8:537–542
Fang JC, Kinlay S, Beltrame J, Hikiti H, Wainstein M, Behrendt D, Suh J, Frei B, Mudge GH, Selwyn AP, Ganz P (2002) Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 359:1108–1113
Freese R, alfthan G, Jauhiainen M, Basu S, Erlund I, Salminen I, Aro A, Mutanen M (2002) High intake of vegetables, berries, and apples combined with a high intake of linoleic or oleic only slightly affect markers of lipid peroxidation and lipoprotein metabolism in healthy subjects. Am J Clin Nutr 76:950–960
Frei B (1999) On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc Soc Exp Biol Med 222:196–204
Fuhrman B, Aviram M (1996) White wine reduces the susceptibility of low density lipoprotein to oxidation. Am J Clin Nutr 63:403–404
Fuhrman B, Aviram M (2001a) Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol 12:41–48
Fuhrman B, Aviram M (2001b) Anti-atherogenicity of nutritional antioxidants. Idrugs 4:82–92
Fuhrman B, Aviram M (2001c) Polyphenols and flavonoids protect LDL against atherogenic modifications. In: Handbook of antioxidants: Biochemical, nutritional and clinical aspects, 2nd edn. Ch. 16, pp 303–336
Fuhrman B, Aviram M (2002) Preservation of paraoxonase activity by wine flavonoids: possible role in protection of LDL from lipid peroxidation. Ann NY Acad Sci 957:321–324
Fuhrman B Oiknine J, Aviram M (1994) Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. Atherosclerosis 111:65–78
Fuhrman B, Lavy A, Aviram M (1995) Consumption of red wine with meals reduces the susceptibility of human plasma and LDL to undergo lipid peroxidation. Am J Clin Nutr 61:549–554
Fuhrman B, Ben-Yaish L, Attias J, Hayek T, Aviram M (1997a) Tomato's lycopene and β-carotene inhibit low density lipoprotein oxidation and this effect depends on the lipoprotein vitamin E content. Nutr Metab Cardiovasc Dis 7:433–443
Fuhrman B, Oiknine J, Keidar S, Ben-Yaish L, Kaplan M, Aviram M (1997b) Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. Free Radic Biol Med 23:34–46
Fuhrman B, Buch S, Vaya J, Belinky PA, Coleman R, Hayek T, Aviram M (1997c) Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 66:267–275
Fuhrman B, Volkova N, Rosenblat M, Aviram M (2000a) Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic. Antiox Redox Signal 2:491–506
Fuhrman B, Rosenblat M, Hayek T, Coleman R, Aviram M (2000b) Dietary consumption of ginger extract attenuates development of atherosclerosis in the atherosclerotic apolipoprotein E deficient mice: hypocholesterolemic and antioxidative effects. J Nutr 130:1124–1131
Fuhrman B, Volkova N, Aviram M (2001) White wine with red wine-like properties: increased extraction of grape skin polyphenols improves the antioxidant capacity of the derived white wine. J Agric Food Chem 49:3164–3168
Fuhrman B, Koren L, Volkova N, Hayek T, Aviram M (2002) Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes. Atherosclerosis 164:179–185
Fuhrman B, Shiner M, Volova N, Aviram M (2004a) Cell-induced copper ion-mediated low density lipoprotein oxidation increases during in vivo monocyte-to-macrophage differentation. Free Radic Biol Med 37:259–271
Fuhrman B, Partoush A, Aviram M (2004b) Acetylcholine esterase protects LDL against oxidation. Biochem Biophys Res Commun 322:974–978
Fuhrman B, Volkova N, Aviram M (2005a) Paraoxonase 1 (PON1) is present in postprandial chylomicrons. Atherosclerosis (in press)
Fuhrman B, Volkova N, Coleman R, Aviram M (2005b) Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. J Nutr (in press)
Futterman LG and Lemberg L (1999) The use of antioxidants in retarding atherosclerosis: fact or fiction? Am J Crit Care 8:130–133
Garin MC, James RW, Dussoix P, Blanche H, Passa P, Froguel P, Ruiz J (1997) Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. Apossible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest 99:62–66
Gerrity RG (1981) The role of monocytes in atherogenesis. Am J Pathol 103:181–190
Gey K, Puska P, Jordan P, Moser UK (1991) Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 53(Suppl):326S–334S
Gianetti J, Pedrinelli R, Petrucci R, Lazzerini G, De Caterina M, Bellomo G, De Caterina R (2002) Inverse association between carotid intima-media thickness and the antioxidant lycopene in atherosclerosis. Am Heart J 143:467–474
Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425–430
Glass CK, Witztum JL (2001) Atherosclerosis: The road ahead. Cell 104:503–516
Greenberg ER, Baron JA, Karagas MR, Stukel TA, Nierenberg DW, Stevens MM, Mandel JS, Haile RW (1996) Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 275:699–703
Halliwell B (1994) Free radicals, antioxidants and human disease: Curiosity, cause, or consequence. Lancet 344:721–724
Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinky P, Coleman R, Elis A, Aviram M (1997) Reduced progression of atherosclerosis in the apolipoprotein E deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol 17:2744–2752
Hayek T, Hussein K, Aviram M, Coleman R, Keidar S, Pavlotxky E, Kaplan M (2005) Macrophage-foam cell formation in streptozoto cin-induced diabetic mice: Stimulatory effect of glucose. Curr Opin Liidol (in press)
Hegele RA (1999) Paraoxonase genes and disease. Ann Med 31:217–224
Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R (1996) Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334:1145–1149
Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342:1007–1011
Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, et al (1995) Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155:381–386
Herttuala SY (1998) Is oxidized low density lipoprotein present in vivo? Curr Opin Lipidol 9:337–344
Hodis HN, Mack WJ, LaBree L, Cashin-Hemphill L, Sevanian A, Johnson R, Azen SP (1995) Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273:1849–1854
Hodis HN, Mack WJ, LaBree L, Mahrer PR, Sevanian A, Liu CR, Liu CH, Hwang J, Selzer RH, Azen SP (2002) VEAPS Research Group Alpha-to copherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 106:1453–1459
Howard A, Chopra M, Thurnham D, Strain J, Fuhrman B, Aviram M (2002) Red wine consumption and inhibition of LDL oxidation: What are the important components? Med Hypothesis 59:101–104
Investigators G (1999) Dietary supplementation with n-3PUFA and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 354:447–455
Ishikawa T, Suzukawa M, Ito T, Yioshida H, Ayaori M, Nishiwaki M, Yonemura A, Hara Y, Nakamura H (1997) Effect of tea flavonoid supplementation on the susceptibility of low density lipoprotein to oxidative modification. Am J Clin Nutr 66:261–266
Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, Schellenberg GD, Heagerty PJ, Hastsukami TS, Furlong CE (2002) Vitamin Cand E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 22:1329–1333
Jialal I, Fuller CJ, Huet BA (1995) The effect of α-tocopherol suplementation on LDL oxidation. A dose-response study. Arterioscler Thromb Vasc Biol 15:190–198
Jialal I, Devaraj S (1996) The role of oxidized low density lipoprotein in atherogenesis. J Nutr 126:1053S–1057S
Jialal I, Devaraj S (2003) Antioxidants and atherosclerosis: don't throw out the baby with the bath water. Circulation 107:926–928
Jialal I, Traber M, Devaraj S (2001) Is there a vitamin E paradox. Curr Opin Lipidol 12:49–53
Kaplan M, Aviram M (1999) Oxidized low density lipoprotein: Atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med 37:777–787
Kaplan M, Aviram M (2004a) Red wine administration to apolipoprotein E-deficient mice reduces their macrophage-derived extracellular matrix atherogenic properties. Biol Res 37:239–245
Kaplan M, Aviram M (2004b) Macrophage-mediated oxidation of LDL and atherogenesis: Protective role for paraoxonase. In: Cellular disfunction in atherosclerosis and diabetes-Reports from bench to bedside. Simionescu M, Sima A, Popov D (eds) Romanian Academy Publishing House, chap 25, pp336–351
Kaplan M, Hayek T, Raz A, Coleman R, Dornfeld L, Vaya J, Aviram M. (2001) Pomegranate juice supplementation to atherosclerotic mice reduces macrophages lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr 131:2082–2089
Kaul N, Devaraj S, Jialal I (2001) A-Tocopherol and atherosclerosis. Exp Biol Med 226:5–12
Keany JF, Simon DI, Freedman JE (1999) Vitamin E and vascular homeostasis: implications for atherosclerosis. FASEB J 13:965–975
Kleemola P, Freese R, Jauhiainen M, Pahlman R, Alfthan G, Mutanen M (2002) Dietary determinants of serum paraoxonase activity in healthy humans. Atherosclerosis 160:425–432
Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A (1994) Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 139:1180–1189
Knekt P, Jarvinen R, Renuanen A, Maatela J (1996) Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 312:478–481
Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A (2002) Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76:560–568
Kohlmeier L, Hasting SB (1995) Epidemiologic evidence of a role of carotenoids in cardiovascular disease prevention. Am J Clin Nutr 62:137S–146S
Kohlmeier L, Kark JD, Gomez-Garcia E, Martin BC, Steck SE, Kardinaal AFM, Ringstad J, Thamm M, Masaev V, Riemersma R, Martin-Moreno JM, Huttunen JK, Kok F (1997) Lycopene and myocardial infarction risk in the EURAMIC study. Am J Epidemiol 146:618–626
Krinsky NI (2001) Carotenoids as antioxidants. Nutrition 17:815–817
Kritenson M, Zieden B, Kucinskiene Z, Elinder LS, Bergdahl B, Elwing B, Abaravicius A, Razinkoviene L, Calkauskas H, Olson A (1997) Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross sectional study of men aged 50. Br Med J 314:629–633
Kritchevsky SB, Tel GS, Shimakawa T, Dennis B I R, Kohlmeier L, Steere E, Heiss G (1998) Provitamin A carotenoid intake and carotid artery plaques: the atherosclerosis risk in communities study. Am J Clin Nutr 68:726–733
Kritchevsky SB (1999) β-carotene, carotenoids and the prevention of coronary heart disease. J Nutr 129: 5–8
Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM (1996) Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. New Engl J Med 334:1156–1162
La Du BN, Adkins S, Kuo CL, Lipsig D (1993) Studies on human serum paraoxonase/arylesterase. Chem Biol Interact 87:25–34
La Du BN (1996) Structural and functional diversity of paraoxonases. Nat Med 2:1186–1187
La Du BN (2001) Is paraoxonase-3 another HDL-associated protein protective against atherosclerosis? Arterioscler Thromb Vasc Biol 21:467–468
Lafont AM, Chai YC, Cornhill JF, Whitlow PL, Howe PH, Chisolm GM (1995) Effect of α-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J Clin Invest 95:1018–1025
Lee CH, Jeong TS, Choi YK, Hyun BH, Oh GT, Kim EH, Kim JR, Han JI, Bok SH (2001) Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM and MCP-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun 15:681–688
Letellier C, Durou MR, Jouanolle AM, Le Gall JY, Poirier JY, Ruelland A (2002) Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications. Diabetes Metab 28:297–304
Levy Y, Kaplan M, Ben-Amotz A, Aviram M (1996) Effect of dietary supplementation of betacarotene on human monocyte-macrophage-mediated oxidation of low density lipoprotein. Isr J Med Sci 32:473–478
Linseisen J, Hoffmann J Riedl J, Wolfram G (1998) Effect of single oral dose of antioxidant mixture (vitamin E, carotenoids) on the formation of cholesterol oxidation products after ex vivo LDL oxidation in humans. Eur J Med Res 3: 5–12
Losonczy K (1996) Vitamin E and vitamin C supplement use and risk of all cause and coronary heart disease mortality in older persons: The established populations for epidemiologic studies of the elderly. Am J Clin Nutr 64:190–196
Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN (1991a) Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 86:193–197
Mackness MI, Arrol S, Durrington PN (1991b) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 286: 152–154
Mackness Mi, Arrol S, Abbott CA, Durrington PN (1993) Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 104:129–135
Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA (1996) Paraoxonases biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 7:69–76
Mackness MI, Boullier H, Hennuyer M, Mackness B, Hall M, Tailleux A, Duriez P, Delfly b, Durrington PN, Fruchart JC, Duverager N, Cailloud JM, Castro G, Bouiller A (2000a) Paraoxonase activity is reduced by a pro-atherogenic diet in rabbits. Biochem Biophys Res Commun 269:232–236
Mackness MI, Durrington PN, Mackness B (2000b) How high-density lipoprotein protects against the effects of lipid peroxidation. Curr Opin Lipidol 11:383–388
Mackness B, Davies GK, Turkie W, Lee E, Roberts DH, Hill E, Roberts C, Durrington PN, Mackness MI (2001) Paraoxonase status in coronary heart disease. Are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol 21:1451–1457
Maor I, Hayek T, Coleman R, Aviram M (1997) Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol 17:2995–3005
Mayne ST (1996) Beta-carotene, carotenoids, and disease prevention in humans. FASEB J 10:690–710
McAnlis GT, McEneny J, Pearce J, Young IS (1998) Black tea consumption does not protect low density lipoprotein from oxidative modification. Eur J Clin Nutr 52:202–206
Meyer F, Bairati I, Dagenais G (1994) Lower ischemic heart disease (IHD) incidence and mortality among vitamin supplement users in a cohort of 2226 men. 2nd International Conference. Antioxidant Vitamins and β-Carotene in Disease Prevention. Berlin
Meister A, Anderson ME (1983) Glutathione. Annu Rev Biochem 52:711–760
Miyagi Y, Miwa K, Inoue H (1997) Inhibition of human low density lipoprotein oxidation by flavonoids in red wine and grape juice. Am J Cardiol 80:1627–1631
Mochizuki H, Scherer SW, Xi T, Nickle DC, Majer M, Huizenga JJ, Tsui LC, Prochazka M (1998) Human PON2 gene at 7q21.3: cloning, multiple mRNA, and missense polymorphism in coding sequence. Gene 213:149–157
Morel I, Lescoat G, Cogrel P, et al. (1993) Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem Pharmacol 45:13–19
Muldoon MF and Kritchevsky SB (1996) Flavonoids and heart disease. BMJ 312:458–459
Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM (1996) The yin and yang of oxidation in the development of the fatty streak: a review based on the 1004 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 16:831–842
Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, Grijalva VR, Navab M, Fogelman AM, Reddy ST (2001) Paraoxonase-2 is an ubiquitously expressed protein with antioxidant properties, and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 276:44444–44449
Nigdikar SV, Williams N, Griffin BA, Howard AH (1998) Consumption of red wine polyphenols reduces the susceptibility of low density lipoproteins to oxidation in vivo. Am J Clin Nutr 68:258–265
Noguchi N, Niki E (1998) Dynamics of vitamin E action against LDL oxidation. Free Radic Res 28:561–572
Oda MN, Bielicki JK, Ho TT, Berger T, Rubin EM, Forte TM (2002) Paraoxonase 1 over-expression in mice and its effect on high-density lipoproteins. Biochem Biophys Res Commun 290:921–927
Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150–1155
Panasenko OM, Sharov VS, Briviba K and Sies H (2000) Interaction of peroxynitrite with carotenoids in human low density lipoproteins. Arch Biochem Biophys 373:302–305
Paolisso G, Esposito R, D'Alessio MA, Barbieri M (1999) Primary and secondary prevention of atherosclerosis: is there a role for antioxidants? Diabetes Metab 25:298–306
Parthasarathy S, Rankin SM (1992) The role of oxidized LDL in atherogenesis. Prog Lipid Res 31:127–143
Parthasarathy S, Santanam N, Auge N (1998) Oxidized low-density lipoprotein, a two-faced janus in coronary artery disease? Biochem Pharmacol 56:279–284
Paiva SA, Russell RM (1999) Beta-carotene and other carotenoids as antioxidants. J Am Coll Nutr 18:426–433
Prasad J (1980) Effect of vitamin E supplementation on leukocyte function. Am J Clin Nutr 33:606–608
Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA (1998) Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice. Nat Med 4:1189–1192
Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN (1996) The human serum paraoxonase/ arylesterase gene (PON1) is one member of a multigene family. Genomics 33:498–507
Princen HM, van Duyvennvoorde W, Buytenhek R, Blonk C, Tijburg LB, Langius JA, Meinders AE, Pijl H (1998) No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol 18:833–841
Pryor WA (2000) Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 28:141–164
Rantala M, Silaste ML, Tuominen A, Kaikkonen J, Salonen JT, Alfthan G, Aro A, Kesaniemi YA (2002) Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women. J Nutr 132:3012–3017
Rao AV (2002) Lycopene, tomatoes and the prevention of coronary heart disease. Exp Biol Med 227:908–913
Rapola J (1997) Randomized trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 349:1715–1720
Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL (1993) Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by β-carotene. Arterioscler Thromb 13:590–600
Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Gangopadhyay A, Shih DM, Lusis AJ, Navab M, Fogelman AM (2001) Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 21:542–547
Redlich CA, Chung JS, Cullen MR, Blaner WS, Van Bennekum AM, Berglund L (1999) Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET). Atherosclerosis 145:425–432
Renaud S, de Lorgeril M (1992) Wine alcohol, platelets and the French paradox for coronary heart disease. Lancet 339:1523–1526
Rice-Evans CA, Miller NJ, Paganga G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933–956
Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC (1993) Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450–1456
Rodrigo L, Hernandez AF, Lopez-Caballero JJ, Gil F, Pla A (2001) Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem Biol Intreact 137:123–137
Rosenblat M, Aviram M (1997) Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL. Free Radic Biol Med 24:305–313
Rosenblat M, Aviram M (2005) Nutritional and pharmacological influences on paraoxonases. Curr Opin Lipidol (in press)
Rosenblat M, Belinky P, Vaya J, Levy R, Hayek T, Coleman R, Merchav S, Aviram M (1999) Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell mediated oxidation of low density lipoprotein. J Biol Chem 274:13790–13799
Rosenblat M, Vaya J, Aviram M (2002) Oxysterols-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: inhibitory role for vitamin E. Atherosclerosis 160:69–80
Rosenblat M, Draganov D, Watson CE, Bisgaier CL, La DU BN, Aviram M (2003) Mouse macrophage paraoxonase 2 (PON2) activity is increased whereas cellular PON3 activity is decreased under oxidative stress. Arterioscler Thromb Vasc Biol 23:468–474
Rosenblat M, Hayek T, Hussein K, Aviram M. (2004) Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy. Arterioscler Thromb Vasc Biol 24:175–180
Rosenblat M, Shih D, Vaya J, Aviram M (2005) Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: A possible role for lysophosphatidylcholine. Atherosclerosis 179:69–77
Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M (2003) Paraoxonase (PON1)-deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic Biol Med 34:774–784
Rozenberg O, Shih D, Aviram M (2005) Paraoxonase 1 (PON1) attenuates macrophage oxidative status: Studies in PON1 transfected cells and in PON1 transgenetic mice. Atherosclerosis (in press)
Salonen JT, Nyyssonen K, Salonen R, Lakka HM, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Lakka TA, Rissanen T, Leskinen L, Tuomainen TP, Valkonen VP, Ristonmaa U, Poulsen HE (2000) Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 248:377–386
Salonen RM, Nyyssonen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen TH, Tuomainen TP, Valkonen VP, Ristonmaa U, Lakka HM, Vanharanta M, Salonen JT, Poulsen HE (2003) Antioxidant Supplementation in Atherosclerosis Prevention Study. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107:947–953
Schaffner T, Taylor K, Bartucci EJ, Fischer-Dzoga K, Beenson JH, Glagov S, Wissler R (1980) Arterial foam cells with distinctive immuno-morphologic and histochemical features of macrophages. Am J Pathol 100:57–80
Serafini M, Ghiselli A, Ferro-Luzzi A (1996) In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr 50:28–32
Shaish A, Daugherty A, O'sullivan F, Shnfeld G, Heinecke JW (1995) Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest 96:2075–2082
Shaish A, George J, Giolburd B, Keren P, Levkovitz H, Harats D (1999) Dietary β-carotene and α-tocopherol combination does not inhibit atherogenesis in an apoE deficient mouse model. Arterioscler Thromb Vasc Biol 19:1470–1475
Sharma MK and Buttner GR (1993) Interaction of vitamin C and vitamin E during free radical stress in plasma: an ESR study. Free Radic Biol Med 14:649–653
Shih DM, Xia YR, Miller E, Castellani LW, Subbanagounder G, Cheroutre H, Faull KF, Berliner JA, Witztum JL, Lusis AJ (2000) Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem 275:17527–17535
Shiner M, Fuhrman B, Aviram M (2004) Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH9)-oxidase-dependent mechanism during monocytes differentation into macrophages. Free Radic Biol Med 37:2052–2063
Sies H and Stahl W (1995) Vitamins E and C, β-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 62(Suppl 6): 1315S–1321S
Smith T, Kummerow F (1989) Effect of dietary vitamin E on plasma lipids and atherogenesis in restricted ovulator chicken. Atherosclerosis 75:105–109
Sorenson RC, Bisgaier CL, Aviram M, XSu C, Billecke S, La Du BN (1999) Human serum paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: apolipoprotein A–I stabilizes activity. Arterioscler Thromb Vasc Biol 19:2214–2225
Sozmen EY, sozmen B, Girgin FK, Delen Y, Azarsiz E, Erdener D, Ersoz B (2001) Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation. Clin Exp Med 1:195–199
Stahl W, Sies H (1997) Antioxidant defense: vitamins E and C and carotenoids. Diabetes 2:S14–S18
Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC (1993) A prospective study of vitamin E supplementation and risk of coronary disease in women. N Engl J Med 328:1444–1449
Stein JH, Keevil JG, Wiebe DA, Aeschlimann S, Folts JD (1999) Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100:1050–1055
Steiner M, Glantz M, Lekos A (1995) Vitamin E plus aspirin compared to aspirin alone in patients with TIA. Am J Clin Nutr 62:1381–1384
Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ (1996) Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781–786
Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272:20963–20966
Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320:915–924
Steiner M, Glantz M, Lekos A (1995) Vitamin E plus aspirin compared to aspirin alone in patients with TIA. Am J Clin Nutr 62:1381–1384
Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ (1996) Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781–786
Stocker R (1999a) The ambivalence of vitamin E in atherogenesis. Trend Biochem Sci 24:219–223
Stocker R (1999b) Dietary and pharmacological antioxidants in atherosclerosis. Curr Opin Lipidol 10:589–597
Street DA, Comstock GW, Salkeld RM, Achuep W, Klag MJ (1994) Serum antioxidant and myocardial infarction: are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction? Circulation 90:1154–1161
Sun J, Giraud SJ, Moxley RA, Driskell JA (1997) β-carotene and α-tocopherol inhibit the development of atherosclerotic lesions in hypercholesterolemic rabbits. Int J Vitam Nutr Res 67:155–163
Suzukawa M, Ayaori M, Shige H, Hisada T, Ishikawa T, Nakamura H (1998) Effect of supplementation with vitamin E on LDL oxidizability and prevention of atherosclerosis. Biofactors 7:51–54
Swain RA, Kaplan MB (1999) Therapeutic uses of vitamin E in prevention of atherosclerosis. Altern Med Rev 4:414–423
Szuchman A, Aviram M, Khatib S, Tamir S, Vaya J (2005) Exogenous tyrosine-linoleate marker as a tool of the characterization of cellular oxidatives stress in macrophages. Biochemistry (in press)
Tavani A, La Vecchia C (1999) Beta-carotene and risk of coronary heart disease. A review of observational and intervention studies. Biomed Pharmacother 53:409–416
Rissanen T, Voutilainen S, Nyyssönen K, Jukka T (2002) Salonen lycopene, atherosclerosis, and coronary heart disease. Exp Biol Med (Maywood) 227:900–907
The HOPE Investigators (2000) Vitamin E supplementation and cardiovascular events in high risk patients: HOPE. N Engl J Med 342:154–161
Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H (1998) Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA 95:3106–3110
Tubaro FP, Rapuzzi F, Ursini U (1999) Kinetic analysis of antioxidant capacity of wine. Biofactors 9:37–47
Tomas M, Senti M, Garcia-Faria F, Vila J, Torrents A, Covas M, Marrugat J (2000) Effect of simvastatin therapy on paraoxonase activity and related proteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol 20:2113–2119
Tomas M, Senti M, Elosua R, Vila J, Sala J, Masia R, Marrugat J (2001) Interaction between the Gln-Arg 192 variants of the paraoxonase gene and oleic acid intake as a determinant of high-density lipoprotein cholesterol and paraoxonase activity. Eur J Pharmacol 432:121–128
Tward A, Xia YR, Wang XP, Shi YS, Park C, Castellani LW, Lusis AJ, Shih DM (2002) Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 106:484–490
Yuting C, Rongliang Z, Zhongjian J, Yong J (1999) Flavonoids as superoxide scavengers and antioxidants. Free Radic Biol Med 9:19–21
Upston JM, Terentis AC, Stocker R (1999)Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement. FASEB J 13:977–994
Ursini F, Tubaro F, Rong J, Sevanian A (1999) Optimization of nutrition: flavonoids and vascular protection. Nutr Rev 57:241–249
Van het Hof KH, de Boer HS, Wiseman SA, Lien N, Westrate JA, Tijburg LB (1997) Consumption of green or black tea does not increase resistance of low density lipoprotein to oxidation in humans. Am J Clin Nutr 66:1125–1132
Verlangieri A, Buxh M (1992) Effects of δ-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 11:131–138
Vinson JA, Hontz BA (1995) Phenol antioxidant index: Comparative antioxidant effectiveness of red and white wines. J Agric Food Chem 43:401–403
Vinson JA, Mandarano MA, Shuta DL, Bagchi M, Bagchi D (2002) Beneficial effects of a novel IH636 grape seed proanthocyanidin extract and a niacin-bound chromium in a hamster atherosclerosis model. Mol Cell Biochem 240:99–103
Visioli F, Micheletta F, Iuliano L (2002) How to select patient candidates for antioxidant treatment? Circulation 106:e195
Wallace AJ, Sutherland WH, Mann JI, Williams SM (2001) The effect of meals rich in thermally stressed olive oil and safflower oils on postprandial serum paraoxonase activity in patients with diabetes. Eur J Clin Nutr 55:951–958
Wen Y, Killalea S, Norris LA, Cooke T, Feely J (1999) Vitamin E supplementation in hyperlipidaemic patients: effect of increasing doses on in vitro and in vivo LDL oxidation. Eur J Clin Invest 29:1027–1034
Wakabayashi Y (1999) Effect of red wine consumption on low density lipoprotein oxidation and atherosclerosis in aorta and coronary artery in Watanabe heritable hyperlipidemic rabbits. J Agric Food Chem 47:4724–4730
Williams RJ, Motteram JM, Sharp CH, Gallagher PJ (1992) Dietary vitamin E and attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 94:153–159
Witztum JL, and Steinberg D (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785–1792
Yamakoshi J, Kataoka S, Koga T, Ariga T (1999) Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 142:139–149
Yoshida N, Murase H, Kunieda T, Toyokuni S, Tanaka T, Terao J, Naito Y, Tanigawa T, Yoshikawa T (2002) Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits. Atherosclerosis 162:111–117
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Aviram, M., Kaplan, M., Rosenblat, M., Fuhrman, B. (2005). Dietary Antioxidants and Paraoxonases Against LDL Oxidation and Atherosclerosis Development. In: von Eckardstein, A. (eds) Atherosclerosis: Diet and Drugs. Handbook of Experimental Pharmacology, vol 170. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27661-0_9
Download citation
DOI: https://doi.org/10.1007/3-540-27661-0_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22569-0
Online ISBN: 978-3-540-27661-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)